Correlation Between HLS Therapeutics and Bionoid Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HLS Therapeutics and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HLS Therapeutics and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HLS Therapeutics and Bionoid Pharma, you can compare the effects of market volatilities on HLS Therapeutics and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HLS Therapeutics with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of HLS Therapeutics and Bionoid Pharma.

Diversification Opportunities for HLS Therapeutics and Bionoid Pharma

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between HLS and Bionoid is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding HLS Therapeutics and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and HLS Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HLS Therapeutics are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of HLS Therapeutics i.e., HLS Therapeutics and Bionoid Pharma go up and down completely randomly.

Pair Corralation between HLS Therapeutics and Bionoid Pharma

Assuming the 90 days horizon HLS Therapeutics is expected to under-perform the Bionoid Pharma. But the pink sheet apears to be less risky and, when comparing its historical volatility, HLS Therapeutics is 4.95 times less risky than Bionoid Pharma. The pink sheet trades about -0.03 of its potential returns per unit of risk. The Bionoid Pharma is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  45.00  in Bionoid Pharma on August 26, 2024 and sell it today you would lose (25.00) from holding Bionoid Pharma or give up 55.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

HLS Therapeutics  vs.  Bionoid Pharma

 Performance 
       Timeline  
HLS Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HLS Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Bionoid Pharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

HLS Therapeutics and Bionoid Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HLS Therapeutics and Bionoid Pharma

The main advantage of trading using opposite HLS Therapeutics and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HLS Therapeutics position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.
The idea behind HLS Therapeutics and Bionoid Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments